Neurostatus has developed an electronic scoring system called Neurostatus e-Scoring to improve the process of assessing patients in multiple sclerosis clinical trials. It allows clinicians to digitally capture examination data on iPads and instantly calculate functional system scores and EDSS scales. To meet regulatory requirements for use in clinical trials worldwide, Neurostatus built a dedicated infrastructure including an app store, secure data transfer, qualified hosting, and IBM Endpoint Manager for mobile device management. This solution addresses the business challenges of managing devices globally at scale while ensuring data quality and compliance.

1. Neurostatus Systems GmbH
Roland John (COO) and Beat Gersbach (CTO)
IBM Health Innovation 2013

2. Table of contents
− Neurostatus e-Scoring
− Business Challenge
− Solution
− Summary, Q&A
05-NOV-2013
Neurostatus Systems GmbH
2

3. Neurostatus e-Scoring
− Electronic Data Capturing
(EDC)
− Clinical Trials
− EDSS scale: Gold Standard to
assess the overall status of
patients in Multiple Sclerosis
– Expanded Disability Status Scale
05-NOV-2013
Neurostatus Systems GmbH
3

4. Background
Full Neurological Examination:
120 Sub-Scores
8 Functional System Scores
1 EDSS Step
05-NOV-2013
Neurostatus Systems GmbH
4

5. Process until now
1.
2.
3.
4.
5.
6.
Analog data capturing (paper)
FS Score and EDSS Step calculation (brainwork)
Data Transfer to Sponsor (Fax)
Digitizing of data (partially)
Quality control (manual calculation)
Queries to EDSS rater
−
−
too many steps
too much time, noise and ressources
bad data quality
05-NOV-2013
Neurostatus Systems GmbH
5

6. Direct and fast !
Bring the solution to the
end user:
−Electronic data capturing
−On site quality control
(e-Scoring Algorithm)
−Instant feedback and data
clarification
Mobile solution
05-NOV-2013
Neurostatus Systems GmbH
6

7. Improved data quality
05-NOV-2013
Neurostatus Systems GmbH
7

8. Numbers
05-NOV-2013
Neurostatus Systems GmbH
8

9. System Components
Neurostatus e-Scoring
Web Application
05-NOV-2013
NS Server
Neurostatus Systems GmbH
iPad
9

10. Business Model
Neurologists / Hospital (End User)
Pharma Companies / Clinical Trials (Customers)
Neurostatus Systems
UHBS, Basel
System development and operations
Prof. Kappos, Scientific background
05-NOV-2013
Neurostatus Systems GmbH
10

11. 350 Sites in 30 Countries
05-NOV-2013
Neurostatus Systems GmbH
11

12. Business Challenges
− Enterprise Level, but worldwide distributed
end users
05-NOV-2013
Neurostatus Systems GmbH
12

13. Regulatory Requirements
− Qualified and Validated infrastructure
according to FDA/EMA regulatory
requirements
− Validated = Controlled and documented
installation according guidelines
Authenticity
05-NOV-2013
Integrity
Neurostatus Systems GmbH
Traceability
13

14. Infrastructure Requirements
− Controlled Access / Profiling
− Secure Data Transfer
− Remote Control
Integrated Neurostatus Infrastructure
05-NOV-2013
Neurostatus Systems GmbH
14

15. Solution
05-NOV-2013
Neurostatus Systems GmbH
15

16. Main Infrastructure Components
− Dedicated App Store (Apple Enterprise Store)
– To be (almost) independent on Apple guidelines
− Mobile Data Communication (Swisscom)
– Secure data transfer; M2M with VPN / APN
− Qualified Infrastructure (Symotech AG)
– Regulatory Compliance
− Mobile Device Management (IBM Endpoint Manager)
– Sophisticated Profiling, Remote Control
05-NOV-2013
Neurostatus Systems GmbH
16

17. Why IBM Endpoint Manager ?
− Multi Platform
– Scalability, Diversification
− Fixlets
– Optimization, Operations and Reporting
− Supports Apple Profiling
– Controls and Restrictions
05-NOV-2013
Neurostatus Systems GmbH
17

18. Operations
− Before delivery
– Staging and Profiling
− After delivery
– Establishing Connectivity remotely
– Support and Maintenance
05-NOV-2013
Neurostatus Systems GmbH
18

19. Summary
− Challenging
− Regulatory compliant but flexible Solution
− Expected growth
− Pros and Cons with Apple
− Close Collaboration with IBM Engineering
05-NOV-2013
Neurostatus Systems GmbH
19

20. Thank you!
05-NOV-2013
Neurostatus Systems GmbH
20